Ophthalmology · Largo, FL
NPI
1316128184
Since 2007
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
148 13th St SW
Largo, FL, 33770
Phone (813) 253-2727
Groups this clinician bills Medicare through
Medicare paid, 2024
$152K
2,271 services
Medicare patients, 2024
782
Average age 77
Drug cost, 2024
$1.1M
8,987 prescriptions
Company payments, 2024
$334
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew J Fabrizio was code 92014 (ophthalmological e&m), 465 times for 446 patients. In total Matthew J Fabrizio billed 2,271 services in 28 codes, and Medicare paid $152K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 465 | 446 | $73.37 | $34K |
| 92083 Vision, Hearing, and Speech Services | Office | 434 | 425 | $42.23 | $18K |
| 92133 Computerized Ophthalmic Imaging | Office | 335 | 335 | $22.52 | $7,544 |
| 99213 Office E&M - Established | Office | 301 | 229 | $53.85 | $16K |
| 99214 Office E&M - Established | Office | 272 | 235 | $81.35 | $22K |
| 92020 Ophthalmological E&M | Office | 92 | 89 | $19.11 | $1,758 |
| 92250 Angiography | Office | 65 | 65 | $24.95 | $1,622 |
| 76514 Ultrasound - Nonspecific | Office | 54 | 54 | $7.78 | $420 |
| 92004 Ophthalmological E&M | Office | 52 | 52 | $96.34 | $5,009 |
| 99212 Office E&M - Established | Office | 52 | 49 | $31.64 | $1,645 |
| 66984 Cataract Surgery | Facility | 24 | 20 | $398.18 | $9,556 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 20 | 16 | $131.04 | $2,621 |
| 92136 Ultrasound - Nonspecific | Office | 18 | 17 | $31.37 | $565 |
| 92025 Test - Miscellaneous | Office | 15 | 15 | $24.08 | $361 |
| 66170 Fluid Flow and Drainage of Eye (Any Method) | Facility | 15 | 14 | $848.38 | $13K |
By year: 2022 $231K for 2,911 services; 2023 $224K for 3,024 services; 2024 $152K for 2,271 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew J Fabrizio prescribed most often to Medicare patients was Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat), with 2,269 prescriptions and refills. In total Matthew J Fabrizio wrote 8,987 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 2,269 | 5,103 | 627 | $44K |
| Latanoprost Generic | 2,250 | 5,324 | 673 | $33K |
| Brimonidine Tartrate Generic | 788 | 1,821 | 230 | $24K |
| Lumigan Bimatoprost | 741 | 1,469 | 203 | $413K |
| Timolol Maleate Generic | 624 | 1,487 | 215 | $9,402 |
| Prednisolone Acetate Generic | 333 | 467 | 167 | $17K |
| Dorzolamide Hcl Generic | 320 | 716 | 101 | $6,459 |
| Travoprost Generic | 192 | 443 | 61 | $43K |
| Combigan Brimonidine Tartrate/Timolol | 172 | 286 | 45 | $63K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 166 | 296 | 40 | $108K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 158 | 342 | 53 | $38K |
| Ciprofloxacin Hcl Generic | 136 | 139 | 102 | $1,536 |
| Simbrinza Brinzolamide/Brimonidine Tart | 101 | 144 | 20 | $25K |
| Alphagan P Brimonidine Tartrate | 87 | 176 | 25 | $40K |
| Acetazolamide Generic | 73 | 135 | 17 | $3,710 |
Brand drugs: 2,470 claims; generic drugs: 6,517 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Matthew J Fabrizio $334 ($334 in general payments such as food, travel and fees) from 5 companies. The largest payer was Alcon Vision LLC with $127.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.